Pholcodine

Sold as Pholtex junior, Pholtex forte, Adco-pholcolint

C₂₃H₃₀N₂O₄398.50 g/mol

(4R,4AR,7S,7aR,12bS)-3-methyl-9-(2-morpholin-4-ylethoxy)-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol

Drag to rotate. Structure from PubChem CID 5311356.

Loading Wikipedia summary

Registration

Applicants: 2
Registrations: 3

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Inova Pharmaceuticals (Pty) Ltd1 of 2 cancelled	Pholtex junior, Pholtex forte	5 mg/5 ml	290013, 320116	Not determined	PI PIL
Adcock ingram limitedCancelled	Adco-pholcolint	syrup	G0749	Not determined	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Pholtex junior EACH 5 ml CONTAINS PHOLCODINE 5 mg	5 mg/5 mlSyrup,	29001329/10.1/0013Approved 20 May 2022	Registered	Not determined	PI PIL
Pholtex forte EACH 5 ml LIQUID CONTAINS PHOLCODINE 15,0 mg	Not listed	32011632/10.1/0116	Cancelled	Not determined	None
Adco-pholcolint syrup 5 ML PHOLCODINE A 4,052 MG	Syrup	G0749	Cancelled	Not determined	None

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Professional information (PI)For healthcare professionalsPholtex junior, Inova Pharmaceuticals (Pty) Ltd Patient information leaflet (PIL)For patients and carersPholtex junior, Inova Pharmaceuticals (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background